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Abstract 
 
Musculoskeletal diseases are widespread, and they affect hundreds of millions of people all around 
the world. Bone defects occurs due to various reasons such as surgeries, fracture and diseases. 
These bone defects need a surgical intervention and are generally treated with state-of-the-art 
grafting techniques such as natural bone grafts and implants. However, even the best available 
corrective treatments have several limitations such as availability, disease transfer, donor site 
scarcity, and immune rejection. Bone remodeling techniques which would support natural bone 
regeneration upon graft implantation, can be used to maximize the efficiency of current grafting 
techniques. In this study, our goal was to understand how cell mediated bone mineralization takes 
place in-vitro and to investigate if mineralized micro-environment has any effect on natural bone 
mineralization. Many studies have shown that the use of Simulated Body Fluid (SBF) has been 
consistent for developing the mineral element when used with gelatin, collagen, or other hydrogels. 
These resulting mineral coated hydrogels have similar morphology and chemistry as that of the 
native mineralized tissue. Thus, we used Simulated Body Fluid to generate pre-mineralized gelatin 
methacrylate samples. On top of these pre-mineralized samples, we encapsulated Bone 
Osteosarcoma cells (SaOs-2) and the culture was maintained for a period of two weeks in 
osteogenic media. From the results of Scanning Electron Microscopy (SEM), we found that the 
mineral component produced by 2X modified Simulated Body Fluid (2X m-SBF) and Bone 
Osteosarcoma Cells was morphologically different. Alizarin red staining showed that calcium 
apatite was present on both Simulated Body Fluid mineralized and SaOs-2 cell-mineralized sides 
of the samples. It was also observed that the mineral laid by SaOs-2 cells in the mineralized (7-
day 2X m-SBF mineralized) environment was denser than that seen in the unmineralized 
  
environment. H&E tests supported Alizarin red test results and detected calcified regions on cell-
laden side of the pre-mineralized samples. Though the results were not clear enough to conclude 
that the rate of mineral deposition by SaOs-2 cells in mineralized environment was higher than 
that of the non-mineralized environment, it can be proved in the future with more trials by using 
different types of bone cell-lines and improved cutting and imaging tools.   
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Chapter 1: Introduction 
Worldwide cases of bone diseases and pathological conditions are increasing every year and are 
predicted to be doubled within the next five years. Thus, the demand for surgical intervention and 
development of new grafting techniques is high 1. Common critical bone defects which may occur 
due to trauma, infection, tumors and load bearing injuries, osteosarcoma, osteogenesis imperfecta, 
fracture, etc. 2–4. Such defects can be corrected by several state-of-the-art grafting techniques i.e. 
autografts, allografts and xenografts. Though all the above-mentioned grafting techniques possess 
risks like immunogenic reaction, donor site damage and rejection, they are the best available 
grafting techniques in the industry at the moment. Polymeric grafts are another way to go, but also 
possess their own risks 3,5. As a result, the average life of a bone graft is around 8-10 years 4,6,7.To 
avoid repeated surgical intervention and to minimize patient discomfort, there is a need to develop 
supporting remodeling techniques which can increase the average life of a bone graft and their 
ability to bond and regenerate natural bone tissue. 
Bone remodeling is a very complex physiological process which involves intricate pathways 
closely coordinated by the actions of four types of bone cells 8–10. Bone remodeling is a process in 
which old bone is completely replaced by new bone tissue. There are very few scientific studies 
which look into the role that bone remodeling plays in repairing a critical size bone defect and how 
bone regeneration occurs when a bone graft is implanted. Hence, development of new mineralized 
tissue models is necessary to understand these remodeling processes 11. These models can further 
help us build tissue engineered techniques to support the current gold standard grafting techniques. 
This would enhance their life and ability to repair bone defects, which in turn would improve 
patients' quality of life.  
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To develop an in-vitro model containing such complex pathways, one must first know the basic 
physiology of bone and how bone remodeling occurs naturally. 
1.1 Bone Physiology: 
There are four major types of bones: Long bones, short bones, flat bones and irregular bones. 80% 
of total bone mass is made up of cortical bone, which is also known as compact bone, whereas, 
the remaining 20% is trabecular bone which is known as cancellous or spongy bone 12. Bone is a 
complex mineralized tissue collectively made of four types of cells namely osteoblasts, osteoclasts, 
osteocytes and bone-lining cells. Osteoblasts, osteocytes and bone lining cells originate from 
mesenchymal stem cells, whereas osteoclasts stem from hematopoietic stem cells 11. Together, 
bone cells form around 10% of the bone as a bulk 13. On the other hand, bone as a mineralized 
composite makes up about 90% of the bone mass. This mineralized composite is comprised of 
organic and inorganic phases embedded within an organic extra-cellular matrix 14. The organic 
part is majorly composed of type I collagen fibrils which are highly organized and forms the 
structural frame for mineral deposition 13,15. The inorganic phase of the bone is predominantly 
composed of carbonated hydroxyapatite crystals and calcium-phosphate minerals. Carbonated 
hydroxyapatite, also known as bone mineral, is a major component which makes up about 70% of 
the bone 12,14,15.  
Bone mineral/apatite formation is one of the most important steps involved in bone remodeling 16. 
Two major mechanisms by which bone apatite is formed are cell-dependent extracellular vesicle 
mineralization and cell-independent matrix mineralization through ion accumulation from ion-rich 
solutions 17–19. Out of the above-mentioned mechanisms, cell mediated mechanism is the most 
common and natural pathway to acquire bone apatite. Amorphous calcium phosphate ions are 
deposited continuously by osteoblasts on the underlying collagen framework, along with 
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hydroxyapatite crystals. They further nucleate due to the surrounding environment and several 
non-collagenous proteins produced by bone extracellular matrix. This converts amorphous 
calcium phosphate into carbonated hydroxyapatite. The inorganic bone mineral, carbonated 
hydroxyapatite crystals and the bone’s ability to remodel provides bone its mechanical strength 
and fracture resistance 11,15,16. 
As mentioned before, the bone possesses the ability to remodel and restructure itself. As per 
alternating mechanical and physical needs, bone skeletal system undergoes continuous changes by 
means of remodeling. Bone remodeling is a complex procedure by which bone renewal takes place 
wherein it maintains mineral homeostasis and bone strength. Bone remodeling occurs at damage 
sites induced by changing mechanical requirements, trauma, unhealed fractures and damaged 
implants. It is achieved through continuous resorption by osteoclasts and formation by osteoblasts. 
Here osteocytes regulate the activities of osteoblasts and osteoclasts as per the need of bone 
proliferation or reduction. Bone remodeling also helps in replacing the old bone and prevents its 
accumulation 11,14,20. 
Bone remodeling involves four multifaceted stages and consecutive actions observed by 
osteoblasts, osteoclasts and osteocytes. The detailed procedure is explained in the following 
section. 
1.2 Osteoblast Mediated Bone Regeneration: 
As mentioned above, cell-mediated matrix mineralization plays a major role in bone 
regeneration/remodeling 21. This cell-mediated bone remodeling involves four phases; specifically 
activation, resorption, reversal and formation 12. 
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In activation and resorption, mononucleated osteoclast precursor cells are activated and they resorb 
the packets of old bone. In the reversal phase, bone resorption is reversed to bone formation. 
Finally, osteoblasts are recruited at the site through bone morphogenic proteins (BMPs) and start 
forming a new bone. Once osteoblasts are recruited at the remodeling site, a matrix made up of 
organic collagen fibrils is first deposited by the osteoblasts to begin mineralization 12,16. In the next 
step towards mineralization, Ca2+ and PO4
3- are accumulated by osteoblasts within the matrix 
vesicles fig.1(A&B). Once enough calcium and phosphate ions are accumulated, the matrix 
vesicles are released from osteoblasts 16. Further, the vesicles continue to accumulate and 
concentrate calcium and phosphate ions fig.1(C). Due to this concentration, precipitation occurs, 
and Ca-P nanocrystals are released in the surrounding environment by matrix vesicles along with 
poorly crystalline calcium phosphate fig. 1(D&E). Due to the surrounding environment and several 
non-collagenous proteins produced by bone extracellular matrix, nucleation of these nanocrystals 
takes place. An amorphous calcium phosphate mineral, hydroxyapatite nanocrystals and 
surrounding environment give rise to carbonated hydroxyapatite together 16,22,23. At the end of the 
formation phase, osteoblasts embedded within the bone matrix either convert themselves into 
osteocytes or undergo apoptosis 12,16. The process of osteoblasts mediated mineral deposition is 
not completely understood yet 17. But, based on the above-mentioned pathway some studies have 
developed in-vitro bone regeneration models which would be explained in the next section. 
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Figure 1: Osteoblast mediated mineralization of native bone 16. 
(A and B) Matrix vesicles in the cell accumulate calcium and phosphate ions in the cytosol and 
mitochondria prior to their release into the surrounding collagen matrix.  
(C) Released vesicles concentrate additional ions until precipitation occurs.  
(D) Apatite crystals are released from the vesicles into the environment and are attracted to the 
acidic fibrils in the ECM.  
(E) Apatite crystals behave as nucleation sites for precipitated nanocrystals, allowing the lattice 
to grow. 
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1.3 In-vitro Models for Bone Development: 
Various tissue engineered models have been presented to understand cell-mediated bone apatite 
formation and to develop techniques to accelerate the natural growth of bone within critical size 
bone defects20 . These defects could occur due to fracture site defects, cancer, surgeries, etc. 2,3. 
Iordachescu et. al. had used an in-vitro self-constructing bone model which had periosteum cells 
seeded inside fibrin gel 24. To mimic the matrix alignment found in both trabecular and cortical 
bone, the group then introduced two beta-tricalcium-phosphate anchors into the fibrin matrix. This 
culture was then maintained over a period of one year. A callus-like matrix structure was observed 
within 10 days of culture, the structure around the anchors was also mineralized within that period. 
Further, the anchors were observed to contract the matrix due to the tension between them and 
caused the cellular and molecular alignment in the direction of the force. A distinct matrix was 
seen being constructed from both the anchors towards the center within 3 weeks. Mineral nodules 
throughout the structure were also seen. These mineralized nodules kept increasing over a period 
of 3 months. The mature bone construct was then developed from 3 months to a 1-year period. 
This model was developed to address normal and pathological bone conditions and for the 
simulation of ossification in both the conditions where biochemical and biomechanical cues could 
be changed easily. The major drawback of this model was the incubation time. The group was 
maintaining the culture for about a period of 1 year, which is a very long time to maintain a culture. 
This made it impossible to conduct multiple trials of the experiment and replication of results. 
Another drawback of the study is that, they did not make any efforts to enhance the bone growth 
which might have resulted in shorter culture period 24.  
Another study done by Robin et. al. tried to investigate osteoblast migration and its increased 
activity in the presence of bone like apatite. They also investigated the role of bone apatite in 
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transitioning osteoblasts to osteocytes 25. For this, the group created three sample groups; one with 
a collagen osteoid matrix and the other two with a mineralized collagenous matrix. On top of these, 
matrices’ osteoblasts were seeded, and the samples were monitored for a period of 28 days.  
Mineralized matrices were prepared by either precipitating bone like apatite platelets in the 
collagen matrix and then immersing the matrix in SBF for 14 days or only by immersion in 1.5x-
SBF. SBF is a solution which has a similar ion concentration as blood plasma, and it can provide 
essential ions required for bone apatite formation. The sample groups containing mineralized 
matrices showed osteoblast migration through the matrices at different time points in contrast to 
collagen osteoid matrix, where osteoblasts remained at the top of the matrix. In conclusion, the 
model prepared by the group demonstrates almost all the conventional steps involved in conversion 
of osteoblasts to osteocytes, e.g. the accumulation of a single layer of osteoblasts on top of the 
matrix. The only difference observed was the entrapment of osteoblasts instead of osteoblast 
migration into the matrix, which was a result of using appropriate density (40 mg/ml), hydration 
and the structure of the matrix. They also concluded that the presence of bone-like apatite is 
necessary for osteoblast migration to reach an entrapped position inside the matrix and for their 
conversion to osteocytes 25. 
There are several other studies which indicate enhanced bone regeneration upon application of 
external electrical stimuli, but the electrical properties of native bone are still unknown.  Our group 
investigated the electrical properties of both naturally produced and simulated body fluid produced 
mineral (Ramos et.al.).  For this, human osteosarcoma cell encapsulated hydrogel constructs were 
incubated in osteogenic media and gelatin methacrylate hydrogel constructs were mineralized by 
incubating them in simulated body fluid. Samples were tested at 1, 7, 14, 21, and 28-day time 
points. It was found that both simulated body fluid produced mineral (1X and 2X) and cell 
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produced mineral showed increasing construct conductivity as mineral mass increased over time. 
This is the first study that measured the changes in the electrical nature of mineralized matrix 
which can be potentially used to develop better in-vitro models 26. 
Based on the above models, our group is proposing an in-vitro model to understand a bone-like 
apatite formation pathway which will be elaborated upon in the next section. 
1.4 Research Approach:  
It has been proven that the formation of carbonated hydroxyapatite is one of the most important 
events involved in bone regeneration/remodeling, as it provides bone its mechanical strength and 
fracture resistance 16. Mineralized tissue is formed in many biological conditions such as spinal 
cord injury, fracture repair, hip and knee implant surgeries, dystrophic calcification, etc. But it is 
difficult to generate bone like apatite in-vitro 24. It is quite challenging to distinguish a normal 
mineralization/apatite formation process from an ambiguous process 27. 
Currently, there are no standing models to understand cell (osteoblast) mediated mineral formation 
pathways due to the complexity of the bone formation process in-vivo. The purpose of this study 
is to establish an in-vitro model which can define an osteoblast mediated bone apatite formation 
pathway. Basically, our goal was to understand how cell mediated bone mineralization takes place 
in-vitro and how we could apply this understanding to support current gold standard techniques. 
Our motive was to investigate the influence of mineralized environment in initiating/turn-over rate 
of bone-biomineralization, i.e. to investigate if the presence of mineralized environment has any 
effect on in-vitro biomimetic mineral deposition and vice-versa. Specifically, to investigate if 
presence of mineralized environment affects mineral deposition rate of osteoblast-like cells.  
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Another aim was to develop a system which can easily be modified to produce and model normal 
or pathological ossified tissue. 
In this study, we used bone osteosarcoma cells as model osteoblast cells. Gelatin Methacrylate 
hydrogel, a denatured collagen derivative mixed with type I collagen acted as a model collagen 
framework to deposit osteoblast produced mineral. Gelatin Methacrylate hydrogel was also used 
to produce simulated body fluid mineralized substrate. Here, SBF was used to mimic the ion 
concentration of blood plasma and to produce bone like apatite on model collagen framework 28,29. 
To create this model, we came up with the idea of an interface where simulated body fluid 
mineralized hydrogel and Saos-2 cells encapsulated hydrogel were attached together to form the 
interface. Here, the bottom mineralized part would act as the underlying bone and the top cell-
laden hydrogel would act as the callus where osteoblasts are recruited to produce new mineral. We 
then quantified the mineral deposited by Saos-2 cells in the presence of mineralized environment. 
This was accomplished by encapsulation of Saos-2 cells in the hydrogel and osteogenic simulation 
of the construct made up of collagen and gelatin methacrylate. 
Detailed explanation of materials used, and tests performed to quantify the desired model is given 
in upcoming sections. 
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Chapter 2: Materials and Methods 
To create such a complex interface model, our group designed a specialized sample holder which 
could hold the sample securely and restrict any contamination which may occur during the 
experimental timeline. As mentioned above, to create a specialized mineral interface, a multistage 
procedure was followed which included a variety of materials. Also, the sample holder was 
designed such that it could be easily modified for additional factors that may be included in future 
designs. Additionally, the experiment consisted of multiple sample types to compare the results 
with natural bone mineralization process. This mineralized interface produced by each sample type 
was then quantified using different techniques like alizarin red, histology techniques, energy 
dispersive X-ray spectroscopy (EDS) and scanning electron microscopy (SEM) To accommodate 
all the above-mentioned requirements, a variety of materials and quantification techniques were 
used, and they are explained in this section.  
2.1 Design and Fabrication of Devices: 
2.1.1 3D Printed Mold Negatives:  
To make Poly-dimethyl Siloxane (PDMS) molds, first plastic mold negatives were 3D printed. 
Three separate mold walls, cylinder and base were designed for the purpose of cell encapsulation 
and were called as holder chips fig.2 (A, B, C). 20.00 mm X 20.00 mm square walls with 15.50 
mm height and 2 mm in thickness and 15.00 mm high cylinder with 12.00 mm dia. were attached 
to 20.00 mm X 20.00 mm X 3.00 mm base plate after printing as shown in fig.2(E). The cylinder 
had a rectangular projection of 4.20 mm X 2.90 mm X 0.50 mm on top of it which served as a 
sample space in the final PDMS mold. Molds with 9 projections of 4.20 mm X 2.90 mm X 0.50 
mm were also designed similarly and were used for making GelMA constructs which were used 
as permineralized base fig.3. Both mold negatives were designed with the help of CAD software 
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(Fusion 360). Acrylonitrile butadiene styrene (ABS) thermoplastic molds were printed using a 3D 
printer (Zortrax M200 high resolution extrusion printer). 
 
Figure 2: Design and fabrication of holder mold: Process Flow. 
(A, B, D): CAD Design for holder mold  
(C): Sample size after encapsulation 4.2 x 2.9 x1 mm (GelMA Sample + Cell laden Sample = 0.5 mm+0.5 
mm)  
(E): Combined Mold after printing: How a final plastic mold negative would look after sticking three parts 
to cast PDMS holder molds  
(F): ABS plastic mold negative after printing (Add a better image)  
(G&I): PDMS holder mold and Final holder mold chip  
(H): Plasma Bonding Technique to bind PDMS holder mold and methacrylated glass slide  
(J): SaOs-2 encapsulation procedure (i) Holder cavity (ii) Osteogenic Media (iii) Encapsulated cells on 
GelMA + Collagen (iv) Pre-mineralized GelMA/ Std GelMA (v) – UV lamp (vi) Pipette containing cell 
solution 
 
2.1.2 PDMS Molds:  
Once, both the mold negatives were printed and assembled, PDMS solution was prepared. For this, 
PDMS base and PDMS curing agent were mixed with a ratio of 10:1. The solution was then mixed 
thoroughly for about 10 minutes and cast onto printed molds. The molds were degassed under 
vacuum for 30 minutes to make sure there were no bubbles in the solution. Finally, they were kept 
in an oven for curing at 60oC for 6 hours.  
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Figure 3: Design and fabrication of sample mold: Process Flow 
(A): CAD Design for mold negative  
(B): PDMS mold fabricated using replica casting method (PDMS solution - PDMS Agent: Base = 1:10)  
(C): Sample size – 4.2 mm x 2.9 mm x 0.5 mm  
(D): GelMA solution was pipetted in mold grooves and Samples were casted using UV light 
 
2.1.3 Glass Slide Modification: 
The glass slides on which the PDMS molds would be attached were treated with 3-(Trimethoxy-
silyl) propyl methacrylate. The process is known as methacrylation. This procedure was performed 
to secure GelMA samples on the glass slides at the bottom of the PDMS mold, so that the samples 
wouldn’t lift off during the experiment. Glass slide modification was also performed to keep 
sample size intact and to avoid any damage while removing the sample from the mold. 
Plain Microscope glass slides (50 mm x75 mm x 1 mm Fisher brand) were cut into 20 mm x25 
mm x 1 mm pieces with the help of a glass cutter and were subjected to an acid clean in Piranha 
Solution (sulfuric acid and 30% wt. hydrogen peroxide, 7:3). Slides were then washed in Millipore 
water and air dried. The glass slides were then set in 50 ml of Ethanol bath 30. Glacial acetic acid 
and 3-(Trimethoxy-silyl) propyl methacrylate were then added to the bath and were kept in the 
bath for 12 hours after which they were the washed and air dried.   
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2.1.4 Low pressure Plasma Activated Bonding: 
 The holder chips were assembled using PDMS molds and methacrylated glass slides to hold the 
sample and the sample solution in place during the experiment to eliminate the risk of damaging 
and infecting the samples. To assemble these holder chips an adhesive layer was deposited on the 
sides of glass slides and PDMS holder molds using a plasma bonding machine. Surfaces which 
needed to be stuck were placed in the plasma bonding chamber for about 40-45 seconds in the 
presence of oxygen.  After assembling holder chips, they were kept in the oven at 60oC for about 
5 minutes to affix the bond fig.2(H).   
2.2 Sample Preparation: 
Various materials were used to prepare different parts of the samples. They were namely Gelatin 
Methacryloyl hydrogel, simulated body fluid, hydrogel made up of Gelatin Methacryloyl and type 
I collagen, Bone Osteosarcoma cell (SaOs-2) line and Osteogenic media. Preparation of these 
components and how they were used to create the required cell laden model is explained in this 
section. 
 2.2.1 Gelatin Methacryloyl Hydrogel (GelMA) Synthesis:  
Gelatin Methacryloyl hydrogel is used as a model biopolymer hydrogel in this experiment31–35. 
The first step of GelMA (Gelatin Methacryloyl, Sigma) synthesis was to mix 10 g Type A Porcine 
skin gelatin in 100 ml DPBS (Dulbecco’s Phosphate Buffer saline) solution at 50oC and stir well. 
8 ml of Methacrylic Anhydride (MA; Sigma) was then slowly mixed to convert Gelatin to Gelatin 
Methacryloyl polymer under no air conditions. To maintain these conditions argon was run 
through the solution 5-10 minutes before adding Methacrylic Anhydride (MA; Sigma). Then, 8 ml 
of methacrylic anhydride was slowly added to the solution with the help of a syringe. After 
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allowing the resulting GelMA solution to react for about three hours, 100ml of DPBS was added 
to the GelMA solution to dilute it. The solution was dialyzed using 12–14 kDa dialysis tubing at 
50 °C for 1 week in distilled water. The solution was then freeze dried for 1 week. The resulting 
GelMA macromer was then stored at -80oC.  
2.2.2 Simulated Body Fluid (SBF) Preparation: 
Simulated body fluid (SBF) is a solution which possesses the same ion concentration as blood 
plasma. SBF was prepared by a conventional protocol stated by Oyane et al. given in Table 1(B)  
28. The paper explains the procedure for preparing 1X m-SBF solution briefly. Reagents for making 
100 ml of m-SBF and their purities was stated in Oyane et al. and given in Table 1(A). The 1X-
mSBF solution contained 141 mM NaCl, 4.0 mM KCl, 0.5 nM MgSO4, 1.0 mM MgCl2, 4.2 mM 
NaHCO3, 3.75 mM CaCl2 and 1.5 mM KH2PO4, and the 2X-mSBF variant contained double of 
these amounts as shown in Table 1(C) 29,36. The pH of the solution was maintained using a buffer 
solution of HEPES dissolved in 0.2 M NaOH. 
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Table 1: Types of Simulated Body Fluids, their Contents and comparison of 1X and 2X m-SBF 
(A) Types of SBFs manufactured their purities and Reagents  
(B) Comparison of ion concentrations of human blood plasma and Simulated Body Fluid  
(C) Comparison between amounts of reagents in preparing 1000 ml of 1X m-SBF and 2X m-SBF. 
 
2.2.3 Construct Mineralization:  
To obtain the final concentration of 10% (w/v) standard GelMA solution, 0.5% (w/v) Lithium 
phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) photo initiator, Millipore water and GelMA 
macromer were added together. 20 µl of resulting 10% standard GelMA solution was auto pipetted 
into the 4.2 mm X 2.9 mm X 0.5 mm deep PDMS pits and UV crosslinked using a handheld 
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Hamamatsu LED Controlled (output power 5 mW/cm2; Hamamatsu C11924-511; Hamamatsu 
Photonics K.K., Japan) for 1 minute. Crosslinked GelMA constructs were then incubated in 2X-
mSBF in the incubator at 37oC for 7 days with SBF being changed daily. The required amount of 
SBF was calculated by the formula given by Takadama et.al. Vs=Sa/10; where Vs is minimum 
incubation volume of SBF and Sa is total surface area of a hydrogel construct36.  After incubating 
the samples for 7 days, the mineralized samples were washed thoroughly with Millipore water to 
remove excess SBF solution. 
2.3 Cell Culture: 
2.3.1 Cell-laden Constructs Encapsulation:  
To obtain a final concentration of 20% (w/v) standard GelMA solution, 0.25% (w/v) Lithium 
phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) photo initiator, Millipore water and GelMA 
macromer were added together. The resulting polymer solution was then filtered using a sterile 
filter and stored in centrifuge tubes at 2o-8o C. Gelation of Collagen I (rat tail; Gibco) was 
performed according to the standard protocol given by Gibco life technologies. dH2O, 1N NaOH 
and Medium 199 were mixed with Collagen I rat tail solution to bring the final concentration of 
collagen solution to be 1.5 mg/ml. 
Human bone osteosarcoma cells (Saos-2; ATCC) were employed as model osteoblast-like cells 
for encapsulation experiments. Cells were cultured using Dulbecco’s Modified Eagle’s Medium 
(DMEM, Life Technologies) with 10% fetal bovine serum (v/v) (Atlanta Biologics), 1% penicillin-
streptomycin (Life Technologies) and 1% GlutaMAX (Life Technologies). Cells were routinely 
passaged as per the manufacturer’s protocol with 0.25% trypsin-EDTA (Life Technologies) and 
stored at 37C with 5% CO2 32. For each encapsulation, Saos-2 cell lines were cultured to full 
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confluence. After counting, centrifuged cells were resuspended into dH2O, 1N NaOH and Medium 
199 mixture so the final concentration would be 2.5x106 cells/mL. 
This cell solution was then mixed with equal fractions of sterile-filtered GelMA solution (20% w/v 
with 0.5% LAP- Lithium phenyl-2,4,6-trimethylbenzoylphosphinate) to bring the final 
concentration of GelMA polymer solution to be 7%. Finally, Collagen I rat tail solution was added 
in equal amounts.  Thus, approximately 50,000 cells would be encapsulated in each construct. 20 
µL of the GelMA + Collagen-cell prepolymer solution was carefully pipetted into a UV sterile 
PDMS holder chip with either 10% GelMA sample or 7 day mineralized 10% GelMA sample at 
the bottom. The sample was cured for 1 min using UV light using a handheld Hamamatsu LED 
Controlled (output power 5 mW/cm2). 
2.3.2 Osteogenic Media:  
Osteosarcoma cells (SaOs-2) cells are human osteoblast like cells, which are generally obtained 
from primary osteosarcoma and possess various osteoblastic features. Though the experiment is 
trying to jot down natural bone healing process, we used Saos2 cells as they are easy to work with 
and robust as well. Encapsulated Saos-2 cells were chemically stimulated once trapped in their 
constructs. This stimulation was performed using induction media which consisted of complete 
DMEM media with 0.1 µM dexamethasone (Sigma Aldrich), 25 µg/ml of L-ascorbic acid-2-
phosphate (AA2P; Sigma Aldrich), and 20 mM of β-glycerophosphate (BGP; Sigma Aldrich) 32. 
Constructs were refreshed with induction media on the day of encapsulation and allowed to be 
stimulated to Day 14. Media was replaced every 2-3 days.  
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2.4 Characterization and Analysis: 
2.4.1 Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray Spectroscopy (EDS): 
SEM analysis was performed on experimental samples after 1 and 14 days of osteogenic 
incubation. Samples were first fixed in 4% Formaldehyde for 24 hours. Samples were then washed 
in Millipore water and cut in a way that the interface at which the cell laden part and pre-
mineralized GelMA part of the construct were combined was exposed. Serial incubation was then 
performed in ethanol baths of increasing concentration (10%, 30%, 50%, 70%, 90%, 100% v/v in 
Millipore water) for one hour for each concentration, before drying under vacuum for 24 hours. 
Samples were mounted on aluminum stubs using carbon tapes and were coated with Au/Pt coating 
under a sputter coater (Edwards) with a current of 20 mA for 25 seconds. Samples were then 
analyzed under an EOL JSM-IT100LA Scanning Electron Microscope. Both SEM imaging and 
EDS analysis were performed under high vacuum and at 10kV and 15kV energies. EDS was 
performed to detect the difference between calcium and phosphate contents on both sides of the 
sample interfaces.  
2.4.2 Histological Analysis: 
Resulting control and experimental constructs were sectioned for mineral on day 1 and 14. 
Constructs were first fixed in a 4% formaldehyde solution and subsequently casted and cured in a 
10% GelMA solution to obtain 6 mm diameter cylinders that were 1 mm thick.  These casts were 
then soaked in a 30% sucrose solution overnight before freezing in Tissue-tek O.C.T compound 
(Electron Microscopy Sciences) within 1 cm3 molds. Frozen samples were then sectioned into 10 
μm slices using a Leica CM3050 cryostat (Leica Biosystems, Germany) at -20°C. For alizarin red 
staining, samples were stained in 40 mM Alizarin red S pH 4.2 (Sigma Aldrich) for 5 minutes, 
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dehydrated in 100% ethanol for 20 seconds, rinsed with xylene and mounted using Permount 
(ThermoFisher). Images of the sections were viewed using a Leica EZ4 W microscope with the 
LAS EZ software. For H&E staining samples were stained with Harris hematoxylin solution for 8 
minutes followed by ammonia water solution (for bluing) for about 1 minute. Samples were then 
counterstained with eosin-Y solution for 1 min and dehydrated twice in 95% alcohol for 5 minutes 
each and washed with xylene for 5 minutes. Samples were mounted using permount 
(ThermoFisher).  
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Chapter 3: Results 
3.1 Material Selection and Construct Casting: 
As mentioned in the materials and methods section, we designed sample holder molds which were 
bonded on methacrylated glass slides. Due to difficulties in recovering the whole PDMS mold 
from a single 3D printed ABS mold negative, we fabricated ABS mold negative in three separate 
parts named base, cylinder and walls. After 3D printing ABS mold negatives, we bonded these 
three parts of ABS molds to fabricate the replica of a single PDMS mold. Making three separable 
parts of ABS molds, made it easier to recover the PDMS molds and we could also reuse ABS mold 
negatives. 
Gelatin Methacryloyl hydrogel is a denatured collagen derivative and it replicates many ECM 
properties. GelMA was selected to be model hydrogel as it provides excellent properties of cell 
adhesion and degradation and can be easily tuned mechanically and biochemically. Another 
hydrogel used while encapsulating cells was type I collagen, as that is the most abundant 
component found in native bone tissue and as they would provide near native environment for 
cells. It was used in accordance with GelMA as, collagen cannot form stiff gels  
3.1.1 Design and Fabrication of Pre-mineralized GelMA Constructs: 
PDMS molds were fabricated using replica casting method and 3D printed mold negatives, as 
described in the materials and methods section. 20µL of 10% GelMA polymer solution was 
pipetted in these single grooved PDMS molds and UV crosslinked. Unreacted GelMA was 
removed by immersing the 10% GelMA samples in Millipore water for 24 hours.  These GelMA 
constructs were then incubated in 2X-mSBF solution for 7 days and SBF was changed daily. After 
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7 days of incubation, pre-mineralized GelMA constructs were washed thoroughly in Millipore 
water to remove excess SBF solution.   
3.1.2 Assembling the Hybrid Sample in the Holder Chip: 
PDMS holder molds were fabricated as mentioned briefly in the materials and methods section 
and given in fig.2.  PDMS holder molds were then bonded with methacrylated glass slides using 
low pressure plasma activated bonding. Holder chips were filled with 10% Ethyl Alcohol and kept 
under UV light overnight for sterilization before cellular encapsulation on the top of pre-
mineralized and standard 10% GelMA constructs. Pre-mineralized GelMA constructs were 
transferred to holder chips. Saos-2 cells are widely used osteoblast-like cell line, was chosen as a 
model cell line to investigate cell-mediated mineral deposition in the presence of pre-mineralized 
constructs 32,37. The cell suspension was mixed with sterile GelMA + Collagen prepolymer and 
pipetted into PDMS holder chips and cured using UV light to obtain cell-laden constructs (50,000 
cells per construct). Constructs were then cultured in osteogenic media for up to 1 and 14 days.  
3.2 Assessment of Hybrid Construct 
3.2.1 Brightfield / Camera images General Observations: 
There were total 2 groups of samples: control groups and experimental groups. Both the sample 
groups were tested at two time points i.e. day 1 and day 14. These time points were chosen to show 
significant differences mainly between the initial and final stages of the experiments, as the culture 
period was short. The only difference between control and experimental groups was that in the 
former, the bottom part of the construct was 10% std GelMA whereas in the latter, the bottom part 
was pre-mineralized in 2X-mSBF for 7 days. It was observed that the samples (controls and 
experimental) that were tested on day 14 out-grew the sample space implying that mineral was 
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produced within the construct at higher rate than expected. In the control samples tested on day 1 
shown in fig.4(A), no part of the sample appeared to be white, whereas in the control samples 
tested on day 14, the cell-laden part of the sample was white as seen in fig4(B). White colour in 
the samples implied that mineral was produced. Experimental samples tested on day 14 were stiff 
compared to other control samples when probed by tweezers. Experimental samples tested on day 
14 shown in fig.4(D) were whiter in colour than control samples tested on day 1 and 14 and 
experimental samples tested on day 1 in fig.4(C) implying that the amount of mineral in 
experimental samples tested on day 14 was more than all the other samples as both sides of the 
interface were mineralized. For experimental samples tested on day 1, only the SBF mineralized 
part of the samples was white implying that the mineral produced was only due to SBF. This is 
because the cell-laden part of the sample was cultured only for a day and was observed to be clear 
and transparent. But when these samples were probed by tweezers, they were found to be stiffer 
than the control sample tested on day 1. Fig.4(E) shows the experimental sample tested on day 14 
and fig.4(F) shows the interface. 
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Figure 4: Brightfield Images - Transition of the samples from day1 to day14 
(A): Day 1 control: 10% GelMA + cell-laden sample  
(B): Day 14 control: 10% GelMA + cell-laden sample  
(C): Day 1 Experimental: 10% GelMA + cell-laden sample  
(D): Day 14 Experimental: 10% GelMA + cell-laden sample  
(E&F): Day 14 Experimental sample: side view: Transparent part- pre-mineralized GelMA side; white 
part indicates mineralized cell-laden part of the sample. 
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Figure 5: SEM analysis of an interface: day 14 experimental group; Scale bar: 100µm 
(A): Cell laden part of sample 
(B): Pre-mineralized GelMA  
3.2.2 Construct Morphology and Elemental Analysis: SEM and EDS analysis 
SEM was performed for morphological analysis of the sample interface29,38. SEM analysis was 
performed on the experimental samples after 14 days of osteogenic incubation. Samples were 
prepared as explained in the materials and methods section. The interface was clearly visible and 
was captured at 110X and 220X magnifications as seen in fig.5(A, B). It was observed that the cell 
laden part was very uneven and was completely covered with mineral apatite, while the pre-
mineralized GelMA construct side was comparatively plain as seen in fig.6(A, E). EDS analysis 
shows a higher amount of Calcium and phosphate mineral on the pre-mineralized GelMA side of 
samples tested on day 14, while the cell-laden side of the same sample shows higher amount of 
Fig.6 (I) shows comparison between mineral contents of cell-laden side and pre-mineralized 
GelMA side of the sample. 
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 Figure 6: SEM and EDS analysis: day14 experimental group 
(A): SEM Image for cell- laden side; (B): Elemental Mapping: Phosphorous; (C): Elemental Mapping: 
Calcium; (D): EDS graphical representation for cell- laden side; (E): SEM Image for pre-mineralized side; 
(F): Elemental Mapping: Phosphorous; (G): Elemental Mapping: Calcium; (H): EDS Graphical 
representation for pre-mineralized side; (I): EDS spectrum: Comparison between mineral contents of cell-
laden and pre-mineralized GelMA sides of a construct.; scale bar: 20µm 
 
 
SBF Mineralized Side Cell Mineralized Side 
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3.2.3 Alizarin Red Analysis: 
Alizarin Red test was performed to detect the presence of calcium apatite mineral in both control 
and experimental samples fig.7 30.  It was observed that in control samples tested on day 1 fig. 7 
(A) no calcium apatite was found in any sectioned slices whereas, samples tested after 14 days of 
incubation showed Alizarin red stains only on the cell-laden part seen in fig.7 (B). Experimental 
samples tested on day 1 showed the presence of calcium apatite mineral only on the base part 
which was the pre-mineralized GelMA side.  No stains were observed the on cell laden part as it 
was incubated in osteogenic media just for a day. The cells did not deposit any mineral in such a  
 
Figure 7: Histological Analysis - Alizarin Red staining; To detect the presence of calcium apatite mineral;  
Here red colour indicates presence of calcium apatite and transparent samples indicates there is no apatite 
present in the samples. Scale bar: 200µm 
(A&B): These are control group samples for day1 and day14. (A)No calcium apatite is present; (B) SaOs-
2 Produced Calcium apatite.  
(C&D): These are experimental group samples for day 1 and 14. (C)SBF produced calcium apatite; (D) 
SaOs-2 Produced Calcium apatite & SBF produced calcium apatite. 
 
27 
 
short incubation time, fig.7(C). Samples tested after 14 days were observed to be completely 
different from the other three groups of samples. Both pre-mineralized GelMA and cell laden parts 
were stained with alizarin red. The major difference was that the number of pores had 
reduced/pores were filled significantly with apatite mineral and the calcium apatite seen in fig.7(D) 
was darker in colour than the apatite found in fig.7(B) Interface was evidently seen in fig.7(D) 
3.2.4 Hematoxylin and Eosin Analysis: 
Hematoxylin and Eosin staining was performed to detect the presence of cells and extra cellular 
matrix components. In H&E staining blue colour corresponds to Hematoxylin which stains the cell 
nucleus blue, calcified regions are stained in dark blue/purple colour and pink colour corresponds  
Fig 8:  Histological Analysis - Hematoxylin &Eosin Staining; Dotted line separates top and bottom parts 
of the sample. Scale bar: 200µm 
Controls: (A) Cell Laden part is stained only (B) Cell Laden part is stained only 
Experiments: (C) Staining on cellular side/ No Staining for GelMA (D) Staining on cellular side / No 
Staining for GelMA 
D1 
D14 
D1 
D14 
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to Eosin which stains extra cellular matrix components and cytoplasm. Here, the light pink colour 
corresponds to the collagen contents of the sample.  The upper parts of the sample shown by dotted 
lines, were stained in blue colour, as they contained SaOs-2 cells with a density of 50,000 
cells/construct.  Here in the control samples fig 8(A&B), the bottom part of the samples is stained 
in light pink colour as it is pure Gelatin methacrylate which is derived from collagen and eosin 
(pink colour) stains collagen and other ECM components.  
In figure 8(C), i.e. the sample taken on day 1 after cell encapsulation, we observed a dark blue line 
in the upper half of the sample. It could be because an error occurred while placing the sample on 
the mounting slide. But it also indicates that all the cells have accumulated on top of the samples 
as they received all the required nutrients through the incubating medium.  
Another interesting observation in H&E analysis was calcification which is stained in dark 
blue/purple colour in image 8(D). The dark purple lesions indicate that there is a highly calcified 
material present in the upper part of the sample and the calcified material was very similar to 
material found in ectopic calcification 39–41. When compared with fig. 8(B), it indicated that the 
rate of mineral deposition by SaOs-2 cells in the mineralized environment is higher than that in 
the unmineralized environment. These results are comparable to that of the alizarin red stains in 
fig. 7(D).  
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Chapter 4: Discussion 
De-novo bone formation has been observed in various natural and clinical physiological 
conditions. Few of them are as follows: Fracture repair mediated by callus formation, in-vitro 
biomimetic mineralization and dystrophic calcification/ heterotrophic bone formation. Though all 
these ossification procedures share some common steps involved in osseous tissue formation, i.e. 
new cartilaginous matrix formation, mineral deposition by means of osteoblasts, conversion of 
amorphous calcium phosphate minerals to hydroxyapatite nanocrystals and presence of anchoring 
proteins (bone morphogenic proteins), the end products (bone like tissue) differ greatly from each 
other 4,11,17. Various research groups working in the field of bone tissue engineering have come up 
with in-vitro models which replicates some of the steps involved in the formation of native bone 
like environment (osseous – bone like tissue formation).  
With this background, we came up with an idea where a fracture like interface was created. Here, 
a pre-mineralized microenvironment was created with the help of simulated body fluid (2X m-
SBF) which provided/ acted as underlying bone like environment where newly recruited osteoblast 
would produce callus like (osseous) tissue with the help of existing mineralized tissue. We used 
SaOs-2 cell line as it provides stable reproducible cell line with an abundant number of cells. 
Additionally, SaOs-2 cells are easy to work with and robust in nature. Also, one of the 
characteristics of SaOs-2 cells is matrix mineralization which was a key interest for our project.  
We performed SEM analysis to characterize mineral production induced by SaOs-2 cells in the 
presence of pre-mineralized environment. Mineral produced at the cell-laden side showed 
morphological differences when compared to the mineral produced in presence of SBF. Mineral 
produced in the presence of 2X-SBF appeared to be spherical in shape whereas cell-produced 
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mineral in presence of pre-mineralized environment appeared to be somewhat crystal like. Since 
we could not reach a conclusion from the differences observed visually, we will need to conduct 
detailed elemental analysis such as Transmission electron microscopy and Raman spectroscopy in 
future experiments. 
Similarly, Alizarin red and H & E staining fig.7 and fig.8 showed calcified lesions at the interface 
which indicated that the mineral produced by cells was growing with the support of underlying 
SBF produced mineral. Mineralized lesions seen in Alizarin red fig.7 and H & E stains fig.8 were 
observed to be similar to the heterotrophic calcified lesions detected under GNAS mutant mice 
skins in Huso et. al. Especially, the H&E stained images were observed to be similar to that of 
callus mediated fracture repair H&E images in control mice tested by Lauing et. al. The densely 
mineralized regions in fig.8(D) were comparable to breast micro-calcification and ectopic 
calcification 42–44. These results indicated that the interface conditions seen in our experiments 
could replicate either dystrophic calcification or bone like callus formation.  
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Chapter 5: Summery 
In this study we tried to investigate how mineralized environment affects rate of osteoblast 
mediated bone-mineral formation by implementing the interface idea as mentioned before. We 
used Gelatin methacrylate as a base sample material which was pre-mineralized using simulated 
body fluid. Bone osteosarcoma cells were encapsulated on the top of these base samples 37. The 
culture was maintained for 14 days. The samples were studied for mineral morphology and mineral 
contents using SEM and SEM-EDS analysis. To confirm the presence of apatite formed by bone 
cancer cells, Alizarin Red tests were run on the samples.  
5.1 Problems Encountered: 
We expected to observe cell migration in the underlying pre-mineralized Gelatin Methacrylate part 
of the sample. To investigate that, our group performed H&E analysis on the samples. 
Unfortunately, we did not observe any cell migration in pre-mineralized gelatin methacrylate 
samples. This could have happened because of several reasons such as the cell type (SaOs-2 bone 
osteosarcoma cell line) we used or the mineralization density at the surface of pre-mineralized 
samples would have been too hard to penetrate for osteosarcoma cells. Another reason that we did 
not observe cell migration could be that, the environment they were encapsulated in was favorable 
than that of the environment we were expecting them to migrate. Instead, all the cells were seen to 
be accumulated at the interface in H&E staining of experimental samples tested on day 1 fig.8(C).  
It was also difficult to analyze the interface as it was almost destroyed during cryo-sectioning of 
the samples. We lost most of the samples in the process as they were very small and prone to 
breakage. Thus, it was nearly impossible to conclude anything from the sample images we had. 
The same problem was also encountered while taking samples for Alizarin red analysis.  
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5.2 Suggested Improvements and Future Directions: 
Though SEM and EDS analysis provided some excellent insights, we couldn’t perform 
transmission electron microscopy to validate the contents of the sample. This is because for TEM 
we need thin sample slices and as mentioned above we were losing either half of the samples while 
cutting them. Another attempt to validate EDS analysis results was to perform Raman 
spectroscopy. The attempt was not successful as the laser beam size was larger than the sample 
size. From the results our group observed that it could have been indicative of a callus-like 
structure or a dystrophic calcification. But, due to problems stated above our group failed to reach 
any definitive conclusion. Considering all of this, it was a bad idea to develop a model with a lack 
of advanced cutting and imaging tools. Different staining techniques can also be used in future 
such as Azan stains which differentiate osteoid like structure from bone like formation, to confirm 
presence of bone like apatite. 
These problems can be solved in future experiments if we develop improved sample cutting tools. 
Also, we can use a variety of materials and cell types to investigate the process of osteoblast 
mediated bone mineralization. This can be done by using human osteoblast cells in combination 
with gelatin matrices or pure bone collagen matrices. Sample size can also be tuned so that variety 
of state-of-the-art imaging techniques can be used in the future studies.  
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